Annual Drug Patent Expirations for PARSABIV
Parsabiv is a drug marketed by Kai Pharms Inc and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
Drug patent litigation for PARSABIV.
This drug has eigthy-eight patent family members in forty-four countries.
The generic ingredient in PARSABIV is etelcalcetide. One supplier is listed for this compound. Additional details are available on the etelcalcetide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
